#Italy #Milan #CDMO #ROIS #CPHI Milan

ROIS Brings Its Brand to Life at CPHI Milan 2026

The pharmaceutical industry is witnessing an exciting transformation as ROIS makes its mark at CPHI Milan 2026 with the launch of its new corporate website and a fresh brand identity. This announcement highlights ROIS's commitment to exemplifying its expanded Contract Development and Manufacturing Organization (CDMO) capabilities worldwide.

The New Era for ROIS

ROIS, previously part of ROVI, is now an independent CDMO boasting over 50 years of experience in sterile manufacturing. The launch of their new corporate website ties in seamlessly with their presence at CPHI Milan, showcasing an array of promotional materials, a redesigned exhibition booth, and engaging digital content. "The new website truly reflects who we are—a contemporary company with robust CDMO capabilities and a family-oriented partnership approach," said CEO, Javier López-Belmonte.

Extensive Manufacturing Capabilities

ROIS stands out with more than 800 million units of annual capacity for prefilled syringes, cartridges, and vials. The firm specializes in sterile fill-finish operations alongside advanced capabilities like cytotoxic manufacturing, lyophilization, and OEB5 containment. This enables them to support a wide range of complex injectable products including biologics, biosimilars, antibody-drug conjugates (ADCs), peptides, GLP-1s, as well as vaccines and mRNA-based therapies. Customers benefit from a network of five manufacturing sites that provide extensive international capacity and regional expertise, ensuring a single, accountable partner for global programs.

Engaging Presentation at CPHI Milan

Between October 6 and 8, during CPHI Milan, attendees will have the opportunity to experience the new ROIS brand identity firsthand across various touchpoints within their exhibition space. This includes corporate brochures, videos, and sophisticated digital displays that collectively communicate ROIS’s dynamic capabilities. The newly revamped website, www.roiscdmo.com, integrates the company’s vast manufacturing network with specialized technologies and services, simplifying the process for pharmaceutical and biotech firms seeking manufacturing solutions.

A Significant Leap Forward

The website launch signifies the next chapter in ROIS's evolution, merging global manufacturing scale with the flexibility and responsiveness inherent in a family-led business. This strategic move positions ROIS to not only meet the current demands of the pharmaceutical industry but to anticipate future needs with agility and innovation. Furthermore, ROIS's dedication to cultivating long-term relationships and personalized partnerships underscores its commitment to customer satisfaction.

Connect with ROIS

CPHI Milan 2026 serves as a pivotal platform for ROIS to communicate its vision and capabilities. For those interested in learning more about ROIS's offerings, they can visit their booth (10C49) at the exhibition or explore the details further at www.roiscdmo.com/events.

With this modern brand identity, ROIS is not only revitalizing its image but also establishing a stronger presence in the competitive landscape of global pharmaceutical manufacturing.